G
Gavril Hercz
Researcher at University of Toronto
Publications - 20
Citations - 3123
Gavril Hercz is an academic researcher from University of Toronto. The author has contributed to research in topics: Bone disease & Renal osteodystrophy. The author has an hindex of 15, co-authored 19 publications receiving 3037 citations. Previous affiliations of Gavril Hercz include University of Washington & Mount Sinai Hospital, Toronto.
Papers
More filters
Journal ArticleDOI
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Geoffrey A. Block,Kevin J. Martin,Angel L.M. de Francisco,Stewart A. Turner,Morrell M. Avram,Michael Suranyi,Gavril Hercz,John Cunningham,Ali K. Abu-Alfa,Piergiorgio Messa,Daniel W. Coyne,Francesco Locatelli,Raphael M. Cohen,Pieter Evenepoel,Sharon M. Moe,Albert Fournier,Johann Braun,Laura C. McCary,Valter J. Zani,Kurt Olson,Tilman B. Drüeke,William G. Goodman +21 more
TL;DR: Cinacalcet lowers parathyroid hormone levels and improves calcium-phosphorus homeostasis in patients receiving hemodialysis who have uncontrolled secondary hyperparathyroidism.
Journal ArticleDOI
The spectrum of bone disease in end-stage renal failure—An evolving disorder
Donald J. Sherrard,Gavril Hercz,York Pei,Norma A. Maloney,Celia M. T. Greenwood,Arif Manuel,Carl Saiphoo,Stanley S. A. Fenton,Gino V. Segre +8 more
TL;DR: It is suggested that peritoneal dialysis, perhaps by maintaining calcium at higher levels, may more effectively suppress the parathyroid gland.
Journal ArticleDOI
Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis
Istvan Mucsi,Gavril Hercz,Robert Uldall,Michaelene Ouwendyk,Robert Francoeur,Andreas Pierratos +5 more
TL;DR: NHD is more effective in controlling serum phosphate levels than CHD, allowing patients to discontinue their phosphate binders completely and to ingest a more liberal diet.
Journal ArticleDOI
Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid function
Gavril Hercz,York Pei,Celia M. T. Greenwood,Arif Manuel,Carl Saiphoo,William G. Goodman,Gino V. Segre,Stanley S. A. Fenton,Sherrard Dj +8 more
TL;DR: The aplastic lesion is the most common form of renal osteodystrophy, with aluminum intoxication implicated in only 1/3 of the cases, and additional risk factors included treatment with peritoneal dialysis, ingestion of calcium carbonate, diabetes mellitus and advanced age.
Journal ArticleDOI
Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
Mei Wang,Gavril Hercz,Gavril Hercz,Gavril Hercz,Sherrard Dj,Sherrard Dj,Sherrard Dj,Norma A. Maloney,Norma A. Maloney,Norma A. Maloney,Gino V. Segre,Gino V. Segre,Gino V. Segre,York Pei,York Pei,York Pei +15 more
TL;DR: The PTH levels that best distinguish patients with low and high bone formation states from those with normal bone formation in a group of 175 dialysis patients without aluminum toxicity are derived.